Lumos Diagnostics is closer than ever to a decision that could redefine its future: an FDA ruling that would open ... Read ...
Cancer drug developer Immutep has landed a major offshore commercialisation deal worth $30 million upfront and as much as ...
Stockhead on MSN
Long Shortz with Rhythm Biosciences: ISO accreditation clears the path for ColoSTAT launch
Rhythm Biosciences has received ISO accreditation for its GeneType business paving the way to launch ColoSTAT. ... Read More ...
Modern analytical data to support upcoming interpretation, drill targeting and updated geological modelling VANCOUVER, BC / ...
Highlights: Cooke drilling outperforming expectations, with broader mineralization than the current model. Cooke budget and metres doubled to ...
Zacks Investment Research on MSN
HOLX stock up 16% in 6 months: Is it still a hold heading into 2026?
Hologic HOLX has seen steady gains over the last six months. Shares of this Massachusetts, MA-based medtech firm rose 16.1%, outpacing the industry’s 15% growth and the broader Zacks Medical sector’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results